Close Menu

NEW YORK ─ Swedish startup Capitainer on Tuesday announced that it has closed on SEK 31 million ($3.7 million) in financing to roll out its qDBS dried-blood-spot testing system.

Stockholm-based Capitainer said the investment comes as it anticipates an increase in demand for dried blood spot sampling for antibody testing to confirm COVID-19 vaccine efficacy. It will use the funds to ramp up production capacity and build a European sales and marketing network.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.